NO20050795L - Forbindelser, blandinger og fremgangsmater for utnyttelse av samme - Google Patents

Forbindelser, blandinger og fremgangsmater for utnyttelse av samme

Info

Publication number
NO20050795L
NO20050795L NO20050795A NO20050795A NO20050795L NO 20050795 L NO20050795 L NO 20050795L NO 20050795 A NO20050795 A NO 20050795A NO 20050795 A NO20050795 A NO 20050795A NO 20050795 L NO20050795 L NO 20050795L
Authority
NO
Norway
Prior art keywords
compounds
compositions
utilizing
methods
same
Prior art date
Application number
NO20050795A
Other languages
English (en)
Inventor
Ashok Bajji
Esther Arranz
Jayasree Srinivasan
Eric Delmar
Original Assignee
Myriad Genetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Myriad Genetics Inc filed Critical Myriad Genetics Inc
Publication of NO20050795L publication Critical patent/NO20050795L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Det er tilveiebrakt forbindelser og farmasøytiske preparater inneholdende disse, som er anvendelige ved terapeutisk behandling eller forebygging av forskjellige sykdommer.
NO20050795A 2002-07-15 2005-02-15 Forbindelser, blandinger og fremgangsmater for utnyttelse av samme NO20050795L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US39626602P 2002-07-15 2002-07-15
US39677302P 2002-07-16 2002-07-16
PCT/US2003/022183 WO2004006858A2 (en) 2002-07-15 2003-07-15 Compounds, compositions, and methods employing same

Publications (1)

Publication Number Publication Date
NO20050795L true NO20050795L (no) 2005-04-12

Family

ID=30118574

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20050795A NO20050795L (no) 2002-07-15 2005-02-15 Forbindelser, blandinger og fremgangsmater for utnyttelse av samme

Country Status (9)

Country Link
US (1) US7547804B2 (no)
EP (1) EP1542699A4 (no)
KR (1) KR20050029209A (no)
CN (1) CN1681487A (no)
AU (1) AU2003251944B2 (no)
CA (1) CA2492593A1 (no)
NO (1) NO20050795L (no)
NZ (1) NZ537858A (no)
WO (1) WO2004006858A2 (no)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2492593A1 (en) 2002-07-15 2004-01-22 Myriad Genetics, Inc. Compounds, compositions, and methods employing same
US8354427B2 (en) * 2004-06-24 2013-01-15 Vertex Pharmaceutical Incorporated Modulators of ATP-binding cassette transporters
MX341797B (es) * 2004-06-24 2016-09-02 Vertex Pharmaceuticals Incorporated * Moduladores de transportadores con casete de union con atp.
FR2872159B1 (fr) * 2004-06-28 2007-10-05 Merck Sante Soc Par Actions Si Nouveaux derives acides carboxyliques phenyliques et leur utilisation dans le traitement du diabete
US7569725B2 (en) 2004-10-21 2009-08-04 Britsol-Myers Squibb Company Anthranilic acid derivatives as inhibitors of 17β-hydroxysteroid dehydrogenase 3
AU2005311782A1 (en) * 2004-11-30 2006-06-08 Myriad Genetics, Inc. Therapeutic formulations
AU2005321960A1 (en) * 2004-12-27 2006-07-06 Myriad Genetics, Inc. Method of treating cancer
EP1979367A2 (en) * 2005-12-24 2008-10-15 Vertex Pharmaceuticals Incorporated Quinolin-4-one derivatives as modulators of abc transporters
LT1993360T (lt) * 2005-12-28 2017-06-12 Vertex Pharmaceuticals Incorporated N-[2,4-bis(1,1-dimetiletil)-5-hidroksifenil]-1,4-dihidro-4-oksochinolin-3-karboksamido kieta forma
WO2007124498A2 (en) * 2006-04-21 2007-11-01 Myriad Genetics, Inc. Method for treating malignancies of hematopoietic lineage
EP2099774A4 (en) * 2006-11-15 2010-11-24 Ym Biosciences Australia Pty L INHIBITORS OF KINASEACTIVITY
AU2013273769B2 (en) * 2006-11-15 2016-05-12 Ym Biosciences Australia Pty Ltd Inhibitors of Kinase Activity
CN101730703B (zh) * 2007-03-16 2012-12-26 中国人民解放军军事医学科学院放射与辐射医学研究所 具有抗增殖活性的苯甲酰胺类衍生物及其药用制剂
CL2008000986A1 (es) 2007-04-06 2008-10-17 Neurocrine Biosciences Inc COMPUESTO DERIVADO DE HETEROCICLOS DE NITROGENO, AGONISTAS DEL RECEPTOR GnRH; COMPOSICION FARMACEUTICA QUE COMPRENDE A DICHO COMPUESTO; Y USO PARA TRATAR UNA AFECCION RELACIONADA CON LAS HORMONAS SEXUALES, ENDOMETRIOSIS, DISMENORREA, ENFERMEDAD DE OV
ES2534573T3 (es) 2007-04-06 2015-04-24 Neurocrine Biosciences, Inc. Antagonistas del receptor de la hormona liberadora de gonadotropina y métodos relacionados con los mismos
US8461189B2 (en) 2007-06-27 2013-06-11 Merck Sharp & Dohme Corp. Pyridyl derivatives as histone deacetylase inhibitors
US8389553B2 (en) 2007-06-27 2013-03-05 Merck Sharp & Dohme Corp. 4-carboxybenzylamino derivatives as histone deacetylase inhibitors
CA2702469A1 (en) 2007-10-19 2009-04-23 Boehringer Ingelheim International Gmbh Ccr10 antagonists
US20100074949A1 (en) 2008-08-13 2010-03-25 William Rowe Pharmaceutical composition and administration thereof
US12458635B2 (en) 2008-08-13 2025-11-04 Vertex Pharmaceuticals Incorporated Pharmaceutical composition and administrations thereof
MX384179B (es) 2009-03-20 2025-03-14 Vertex Pharma Proceso para producir moduladores del regulador de conductancia transmembrana de fibrosis quística.
US20110128535A1 (en) * 2009-11-30 2011-06-02 David Eugene Baker Nano-Structured Substrates, Articles, and Methods Thereof
US10640457B2 (en) 2009-12-10 2020-05-05 The Trustees Of Columbia University In The City Of New York Histone acetyltransferase activators and uses thereof
US8912184B1 (en) 2010-03-01 2014-12-16 Alzheimer's Institute Of America, Inc. Therapeutic and diagnostic methods
KR20130044382A (ko) * 2010-03-01 2013-05-02 마이렉시스 인코포레이티드 화합물 및 그의 치료 용도
US8802700B2 (en) 2010-12-10 2014-08-12 Vertex Pharmaceuticals Incorporated Modulators of ATP-Binding Cassette transporters
EP3323813B1 (en) * 2010-12-22 2020-08-26 The Trustees of Columbia University in the City of New York Histone acetyltransferase modulators and uses thereof
JP2015511583A (ja) 2012-02-27 2015-04-20 バーテックス ファーマシューティカルズ インコーポレイテッドＶｅｒｔｅｘ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃｏｒｐｏｒａｔｅｄ 薬学的組成物およびその投与
WO2013169939A2 (en) 2012-05-08 2013-11-14 Aeromics, Llc New methods
EP3007689B1 (en) 2013-01-10 2018-03-07 Pulmokine, Inc. Non-selective kinase inhibitors
GB201317609D0 (en) 2013-10-04 2013-11-20 Cancer Rec Tech Ltd Inhibitor compounds
EP3054937B1 (en) 2013-10-11 2023-07-26 Pulmokine, Inc. Spray dry formulations
WO2015065919A1 (en) 2013-10-28 2015-05-07 The Regents Of The University Of California Treatment of metastatic prostate cancer
CA2929821A1 (en) 2013-11-06 2015-05-14 Aeromics, Inc. 2-{[3,5-bis(trifluoromethyl)phenyl]carbamoyl}-4-chlorophenyl dihydrogen phosphate formulations and kits
EP3204358B1 (en) 2014-10-07 2018-09-19 Vertex Pharmaceuticals Incorporated Co-crystals of modulators of cystic fibrosis transmembrane conductance regulator
GB201505658D0 (en) 2015-04-01 2015-05-13 Cancer Rec Tech Ltd Inhibitor compounds
CA3012133A1 (en) 2016-02-09 2017-08-17 Inventisbio Inc. Inhibitor of indoleamine-2,3-dioxygenase (ido)
DK3423451T3 (da) 2016-03-01 2022-11-28 Propellon Therapeutics Inc Inhibitorer af wdr5-protein-proteinbinding
WO2017147701A1 (en) 2016-03-01 2017-09-08 Ontario Institute For Cancer Research (Oicr) Inhibitors of wdr5 protein-protein binding
GB201617103D0 (en) 2016-10-07 2016-11-23 Cancer Research Technology Limited Compound
KR20230093341A (ko) 2016-10-27 2023-06-27 풀모킨 인코포레이티드 폐고혈압을 치료하기 위한 병용 요법
WO2018136650A1 (en) * 2017-01-19 2018-07-26 The Regents Of The University Of California Compositions and methods for treating androgen-independent cancer
WO2019094732A1 (en) * 2017-11-10 2019-05-16 Academia Sinica Inhibitors of cyclic-amp response element-binding protein
AU2019200683B2 (en) * 2018-02-01 2024-05-30 The University Of Sydney Anti-cancer compounds

Family Cites Families (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE106030C (no)
DE112255C (no)
NL291531A (no) * 1962-04-20 1900-01-01
FR1431689A (fr) 1964-09-15 1966-03-18 Dow Chemical Co Procédé de préparation d'un mélange de produits de bromuration de salicylanilide
GB1108393A (en) 1964-12-07 1968-04-03 Unilever Ltd Halogenated phenoxysalicylanilides
US3577550A (en) * 1968-05-02 1971-05-04 Dow Chemical Co N-(phenoxy)phenyl-salicylamides and their utilization as molluscidides
GB1226438A (no) * 1968-12-03 1971-03-31
US3674850A (en) * 1969-12-07 1972-07-04 Lever Brothers Ltd Substituted salicylanilides
US3798258A (en) * 1970-03-13 1974-03-19 Merck & Co Inc Salicylanilides
US3715395A (en) * 1970-09-11 1973-02-06 Merck & Co Inc Substituted thiobenzanilides
DE2126149A1 (en) 1971-05-26 1972-12-07 Farbenfabriken Bayer Ag, 5090 Leverkusen Halo-salicylanilide derivs - with acaricidal and fungicidal activity
US3914418A (en) * 1971-09-02 1975-10-21 Merck & Co Inc Methods of controlling liver fluke infections
SU697500A1 (ru) 1977-02-14 1979-11-15 Ордена Трудового Красного Знамени Институт Медицинской Паразитологии И Тропической Медицины Им. Е.И.Марциновского Салициланилиды, обладающие антигельминтной активностью
FR2434143A1 (fr) 1978-08-25 1980-03-21 Esteve Int Prod Nouveaux derives de salicylamides, leur preparation et leur application en tant que medicaments
JPS58128365A (ja) 1982-01-27 1983-07-30 Fujisawa Pharmaceut Co Ltd ５−スルフアモイルサリチルアミド誘導体、その製造法および用途
DD220902A1 (de) 1983-12-21 1985-04-10 Bitterfeld Chemie Bakterizide mittel
SU1587042A1 (ru) 1988-07-25 1990-08-23 Институт медицинской паразитологии и тропической медицины им.Е.И.Марциновского 1-Хлор-4-(2-нитро-4-хлорфенокси) нафталин в качестве промежуточного продукта в синтезе 2-окси-3,5-дииод-N-[2-(4-хлорнафтокси-1)-5-хлорфенил]бензамида, обладающего противомал рийной активностью
SU1547248A1 (ru) 1988-07-25 1991-04-07 Институт медицинской паразитологии и тропической медицины им.Е.И.Марциновского 1-Бром-4-(2-нитро-4-хлорфенокси)-нафталин, как исходный продукт дл синтеза 2-окси-3,5-дийод-N-[2-(4-бромнафтокси-1)-5-хлорфенил]-бензамида, обладающего противомал рийной активностью
SU1547251A1 (ru) 1988-07-25 1991-04-07 Институт медицинской паразитологии и тропической медицины им.Е.И.Марциновского 2-Окси-3,5-дийод-N-[2-(4-галогеннафтокси-1)-5-хлорфенил]-бензамиды, обладающие противомал рийной активностью
DE69026900T2 (de) * 1989-10-18 1996-10-17 Fuji Photo Film Co Ltd Farbphotographisches Silberhalogenidmaterial und Cyan- kuppler vom 2-Phenylureido-5-acylaminophenol-Typ
JPH03288849A (ja) 1990-04-06 1991-12-19 Fuji Photo Film Co Ltd ハロゲン化銀カラー写真感光材料
JP2943943B2 (ja) 1990-11-29 1999-08-30 富士写真フイルム株式会社 ハロゲン化銀カラー写真感光材料
WO1992013828A1 (fr) 1991-02-08 1992-08-20 Yamanouchi Pharmaceutical Co., Ltd. Nouveau derive de benzanilide ou son sel
TW249201B (no) 1992-07-02 1995-06-11 Otsuka Pharma Co Ltd
JPH06161059A (ja) 1992-11-20 1994-06-07 Konica Corp ハロゲン化銀カラー写真感光材料
JPH06167782A (ja) 1992-11-30 1994-06-14 Konica Corp ハロゲン化銀カラー写真感光材料
JPH0782413A (ja) 1993-09-14 1995-03-28 Teijin Ltd 紫外線吸収剤及び樹脂組成物
JPH07175184A (ja) 1993-12-21 1995-07-14 Konica Corp ハロゲン化銀カラー写真感光材料
JPH07234484A (ja) 1994-02-23 1995-09-05 Konica Corp ハロゲン化銀カラー写真感光材料
US5552426A (en) * 1994-04-29 1996-09-03 Eli Lilly And Company Methods for treating a physiological disorder associated with β-amyloid peptide
CZ104795A3 (en) 1994-04-29 1996-02-14 Lilly Co Eli Benzimidazole derivative, process of its preparation, its use for preparing a pharmaceutical preparation and the pharmaceutical composition containing thereof
DE4428380A1 (de) * 1994-08-11 1996-02-15 Bayer Ag 4-Trifluormethylbenzamide
GB9511694D0 (en) * 1995-06-09 1995-08-02 Fujisawa Pharmaceutical Co Benzamide derivatives
PL325277A1 (en) * 1995-08-30 1998-07-20 Bayer Ag Acylamino salicylamide compounds
AU2139097A (en) 1996-03-01 1997-09-16 Eli Lilly And Company Methods of treating or preventing sleep apnea
CA2248013A1 (en) * 1996-03-11 1997-09-18 Eli Lilly And Company Methods of treating or preventing interstitial cystitis
JPH09268169A (ja) * 1996-04-01 1997-10-14 Otsuka Chem Co Ltd サリチル酸アニリド誘導体、それを有効成分として含む植物病害防除剤
JP3654703B2 (ja) 1996-04-24 2005-06-02 富士写真フイルム株式会社 イソチアゾリルアゾフェノール色素及びそれを利用するカラー写真感光材料
DE19629828A1 (de) 1996-07-24 1998-01-29 Bayer Ag Carbanilide
US6030992A (en) * 1997-02-26 2000-02-29 Eli Lilly And Company Methods of treating or preventing sleep apnea
US5755999A (en) * 1997-05-16 1998-05-26 Eastman Kodak Company Blue luminescent materials for organic electroluminescent devices
US6203979B1 (en) * 1998-01-16 2001-03-20 Incyte Pharmaceuticals, Inc. Human protease molecules
AU3665199A (en) 1998-04-29 1999-11-16 Vertex Pharmaceuticals Incorporated Inhibitors of impdh enzyme
WO2000003975A2 (en) 1998-07-16 2000-01-27 Aventis Agriculture Ltd. Aryl vinyl ether derivatives and their use as herbicides
CA2339765C (en) 1998-08-07 2009-04-28 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US6653309B1 (en) * 1999-04-26 2003-11-25 Vertex Pharmaceuticals Incorporated Inhibitors of IMPDH enzyme technical field of the invention
JP2003510304A (ja) 1999-09-29 2003-03-18 ノボ ノルディスク アクティーゼルスカブ 新規芳香族化合物
US6590118B1 (en) * 1999-09-29 2003-07-08 Novo Nordisk A/S Aromatic compounds
EP1328507B1 (en) * 2000-10-02 2007-03-14 The Research Foundation Of State University of New York Naphthylsalicylanilides as antimicrobial and antiinflammatory agents
CN101849953B (zh) * 2000-12-18 2012-04-25 株式会社医药分子设计研究所 炎症性细胞因子产生游离抑制剂
EP1314712A4 (en) 2001-03-27 2004-12-15 Daiichi Suntory Pharma Co Ltd NF-KAPPA-B INHIBITOR CONTAINING SUBSTITUTED BENZOIC ACID DERIVATIVE AS ACTIVE INGREDIENT
US20060019958A1 (en) 2002-06-05 2006-01-26 Susumu Muto Immunity-related protein kinase inhibitors
JPWO2003103648A1 (ja) 2002-06-05 2005-10-06 株式会社医薬分子設計研究所 糖尿病治療薬
WO2003103647A1 (ja) 2002-06-05 2003-12-18 株式会社医薬分子設計研究所 Ａｐ−１及びｎｆａｔ活性化阻害剤
CN1658872B (zh) 2002-06-06 2010-09-22 株式会社医药分子设计研究所 抗过敏药
EP1535609A4 (en) 2002-06-10 2009-01-07 Inst Med Molecular Design Inc Nf-kb activation inhibitors
CA2488974A1 (en) 2002-06-10 2003-12-18 Institute Of Medicinal Molecular Design, Inc. Medicament for treatment of cancer
EP1555018A4 (en) 2002-06-11 2009-01-07 Inst Med Molecular Design Inc MEANS FOR THE TREATMENT OF NEURODEEGENERATIVE DISEASES
EP1525183A1 (en) * 2002-07-01 2005-04-27 Pharmacia & Upjohn Company LLC Inhibitors of hcv ns5b polymerase
CA2492593A1 (en) 2002-07-15 2004-01-22 Myriad Genetics, Inc. Compounds, compositions, and methods employing same
KR20060054308A (ko) 2003-07-16 2006-05-22 가부시키가이샤 이야쿠 분지 셋케이 겐쿠쇼 피부 색소침착의 치료제

Also Published As

Publication number Publication date
US20050187300A1 (en) 2005-08-25
AU2003251944A1 (en) 2004-02-02
WO2004006858A2 (en) 2004-01-22
KR20050029209A (ko) 2005-03-24
CA2492593A1 (en) 2004-01-22
AU2003251944B2 (en) 2008-06-26
NZ537858A (en) 2008-04-30
EP1542699A4 (en) 2009-03-25
EP1542699A2 (en) 2005-06-22
CN1681487A (zh) 2005-10-12
US7547804B2 (en) 2009-06-16
WO2004006858A3 (en) 2004-04-29

Similar Documents

Publication Publication Date Title
NO20050795L (no) Forbindelser, blandinger og fremgangsmater for utnyttelse av samme
NO20055832L (no) Fremstilling og anvendelse av arylalkylsyrederivater for behandling av fedme
NO20055894L (no) Fremgangsmater og blandinger for behandling av amyloidrelatertere sykdommer
NO20055863L (no) W-karboksyarylsubstituerte difenylureaforbindelser som raf-kinaseinhibitorer
NO20050525L (no) Benzimidazol-1-yl-tiofenforbindelser for behandling av cancer
NO20085373L (no) P38 inhibitorer, deres fremstilling og anvendelse
SE0301700D0 (sv) Novel compounds
NO20052923L (no) Fusjonerte bicykliske nitrogeninneholdende heteroringer
NO20072352L (no) Forbindelser og sammensetninger som inhibitorer av cannabinoidreceptor 1-aktivitet
TW200600087A (en) Methods and compositions for treating amyloid-related diseases
DK1656372T3 (da) 2,4-pyrimidindiaminforbindelser til anvendelse til behandling eller forebyggelse af autoimmunsygdomme
WO2003073999A3 (en) Pini-modulating compounds and methods of use thereof
DK1206474T3 (da) Sulfonylphenylpyrazolforbindelser anvendelige som cox-2-inhibitorer
NO20052888L (no) Diamintriazoler anvendelige som inhibitorer av proteinkinaser
WO2003080582A3 (de) Fredericamycin-derivate
WO2003074550A3 (en) Pin1-modulating compounds and methods of use thereof
NO20061080L (no) Kondenserte pyramidinforbindelser som inhibitorer av spenningsstyrte ionekanaler
DK1412357T3 (da) Beta-aminotetrahydroimidazo-(1,2-a)-pyraziner og tetrahydrotriazolo-(4,3-a)-pyraziner som dipeptidylpeptidaseinhibitorer til behandling eller forebyggelse af diabetes
NO20052761L (no) Spirocykliske cykloheksanderivater.
NO20045301L (no) Substituert 1,3-diphenylprop-2-en-1-one derivat, fremstilling og anvendelse derav.
DE50310516D1 (de) Fredericamycin-derivate
IS8071A (is) Aðferð við meðhöndlun á hnútahersli, fitudreyra og tengdum ástands tegundum og lyfjafræðilegum samsetningum
DK1641803T3 (da) Thienopyrimidinderivater som kaliumkanalinhibitorer
PL1654253T3 (pl) Podstawione pochodne 3-pirolidynoindolu
GB0222514D0 (en) Organic compounds

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application